The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists, Patient Advocacy Efforts Make a Difference

Rheumatologists, Patient Advocacy Efforts Make a Difference

September 15, 2015 • By E. William St.Clair, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Building a team is more than just X’s and O’s; it’s about communicating trust and building confidence in your players.

Building a team is more than just X’s and O’s; it’s about communicating trust and building confidence in your players.
Image Credit: Oez/shutterstock.com

We’re in this together for rheumatology and our patients. Those who know me appreciate my devotion to Duke Basketball and my pride in their recent NCAA championship. Coach K (Krzyzewski), a firmly established leader in the world of college basketball, makes the analogy that a basketball team is like five fingers on a hand, and when they function as a well-oiled team, they act as a fist. A group of talented individuals does not necessarily translate into a successful team. And it’s not all about X’s and O’s; it’s about communicating trust and building confidence in your players. All fingers are pointing in the same direction.

You Might Also Like
  • The ACR’s Grassroots Advocacy Efforts Rely on Rheumatology Patients
  • Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017
  • Your Patients Can Make a Difference—Get Them Involved with Advocacy!
Explore This Issue
September 2015
Also By This Author
  • Building on Accomplishments

Over the years, I have seen how team defines the way we conduct advocacy activities in the American College of Rheumatology (ACR). I wish to share some of my observations and the ways we can combine our efforts to create victories on the advocacy field for our patients, practices and rheumatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Some Victories, & Some Big Moments Ahead

Over the past several years, the ACR has collectively ramped up its efforts in advocacy. I’m proud to say that this year has been marked by considerable progress under the leadership of Dr. Will Harvey and the other members of Government Affairs Committee, and with the combined advocacy efforts of many ACR members. We worked collaboratively with other professional groups to finally defeat the SGR by passing repeal legislation. We also worked together to delay the launch of ICD-10 until this October and played a leading role in the introduction of an ICD-10 safe harbor implementation period. CMS recently announced that claims will not be rejected during the next year because of selecting the wrong ICD‑10 subcode, a small victory for doctors.

We helped introduce federal legislation that combats high patient cost-sharing, enlisting an array of cosponsors on both sides of the aisle. We’ve engaged insurance companies that create barriers for our patients who must take costly biologic medicines to control their disease. We aided efforts to repeal the sequester cuts, especially to Part B drug payments.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, we advanced legislation to reduce Meaningful Use reporting and administrative burdens for rheumatologists and other providers; CMS agreed to enact those provisions administratively.

Importantly, we have continued to aggressively support increased NIH funding for research.

Implementation of MACRA is a sea change for academic & hospital-based practices, & it has the potential to be an existential threat to many in private practice.

But we also face many threats across rheumatology and, in particular, the many new administrative burdens facing rheumatologists—especially solo practitioners and those working in small groups. Insurance companies are merging into powerful behemoths and building more and more roadblocks to timely and effective therapy by enacting burdensome preauthorization requirements, forcing patients to follow a stepwise treatment approach and implementing other tactics to save them money.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: President's Perspective, Professional Topics Tagged With: AC&R, Advocacy, American College of Rheumatology, Patients, Professional Matters, rheumatologists, rheumatologyIssue: September 2015

You Might Also Like:
  • The ACR’s Grassroots Advocacy Efforts Rely on Rheumatology Patients
  • Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017
  • Your Patients Can Make a Difference—Get Them Involved with Advocacy!
  • Five Quick Ways To Make a Difference in Rheumatology Through Advocacy

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.